This content is machine translated Rheumatoid arthritis New JAK inhibitor raises hopes Treatment with disease-modifying antirheumatic drugs (DMARDs) plays an important role in modern therapeutic concepts for rheumatoid arthritis. If left untreated, joint destruction and loss of mobility are possible consequences of…
View Post 2 min This content is machine translated Stroke Secondary Prevention Ticagrelor as add-on leads to significant risk reduction Results from the Phase III THALES trial show that ticagrelor, when taken concomitantly with aspirin, produces a statistically significant and clinically meaningful reduction in stroke recurrences compared with aspirin treatment…
View Post 2 min This content is machine translated Hyposensitization New option for allergy to ragweed Ragweed is highly allergenic and is also causing problems for more and more allergy sufferers in Switzerland. In Germany, an allergen tablet for specific immunotherapy (SIT) for allergies to ragweed…
View Post 4 min This content is machine translated Pulmonary fibrosis in systemic sclerosis More light than shadow Systemic sclerosis (SSc) is one of the most serious diseases because it occurs everywhere in the body, but there is a solution for few problems and virtually every organ must…
View Post 2 min This content is machine translated Disease Management “Face up to rosacea”: contributing to the promotion of the doctor-patient dialogue Launched in 2019, the campaign aims to provide sufferers with knowledge about their chronic inflammatory skin disease and promote empowerment. Web-based disease management tools include the ability to create a…
View Post 3 min This content is machine translated Apremilast “Real-world evidence” in plaque psoriasis with limited skin involvement. The results of the international multicenter study APPRECIATE show a significant symptom reduction including skin involvement of specific sites. In addition, a significant improvement in quality of life was measurable.
View Post 2 min This content is machine translated Pharmacoresistant focal epilepsy. Innovative neurostimulation procedure raises hope Epilepsy is considered one of the most common chronic neurological conditions and severely limits the quality of life of those affected. Despite a wide range of options, current therapeutic options…
View Post 3 min This content is machine translated Atopic dermatitis Reduction of the exacerbation rate by strengthening the barrier function The evidence-based efficacy of two new preparations for the interval and acute treatment of atopic dermatitis is based on a targeted influence on the skin barrier. A special combination of…
View Post 2 min This content is machine translated Application for approval Alzheimer’s drug to be submitted for approval After consultation with the U.S. Food and Drug Administration (FDA), the manufacturer Biogen plans to submit aducanumab for approval. The Phase 3 EMERGE study met its primary endpoint and demonstrated…
View Post 3 min This content is machine translated Guselkumab High response rate maintained over 4 years Recently presented long-term data from the VOYAGE 1 Phase III clinical trial demonstrate that 84% of patients continued to achieve PASI-90 at 204 weeks.
View Post 3 min This content is machine translated Treatment of osteoarthritis Study results show strengthening of total cartilage thickness Approximately 237 million people worldwide are affected by symptomatic and activity-limiting osteoarthritis (OA). Among disabling conditions, OA has the third fastest growth, with the knee joint being the most commonly…
